ALPL and chronic kidney disease: Furthermore, a trend towards increased osteoid area, –width and –perimeter was found in SBI-425-treated CKD rats, which became significant in CKD rats treated with a combination of TNAP inhibitor and PPi as compared to both control rats and vehicle-treated CKD rats.